PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165
This innovative procedure targets fat under your chin, giving you the sleek, contoured look you desire
Reported side effects are typically mildsuch as injection-site irritation, headache, or fatiguebut regulatory reviews highlight potential immunogenicity and uncertainties around long-term safety and product quality in compounded or nonapproved forms
This includes starting with big doses, then keeping up with smaller ones
Because Vitamin B12 is primarily found in animal products such as meat, dairy, and eggs, some individuals, especially vegans and those with certain medical conditions, are at risk for deficiency
Potential Risks and Side Effects The FDA states that compounded drugs containing AOD-9604 carry a significant risk for immunogenicity